Dr. Justin Moser, MD
Claim this profileHonorHealth Research Institute
Area of expertise
Solid Tumors
Justin Moser, MD has run 6 trials for Solid Tumors. Some of their research focus areas include:
Melanoma
Justin Moser, MD has run 5 trials for Melanoma. Some of their research focus areas include:
Affiliated Hospitals
HonorHealth Research Institute
HonorHealth Research And Innovation Institute
Clinical Trials Justin Moser, MD is currently running
ODC-IL2
for Cancer
This is a first-in-human, Phase I, multicenter, open-label, dose escalation study with dose expansion to evaluate the safety and antitumor activity of ODC-IL2 in patients with advanced or metastatic solid tumors. ODC-IL2 is a conditionally activated IL-2 prodrug and will be administered as a single agent via intravenous infusion on Days 1 and 15 of a 28-day cycle. Up to approximately 50 patients will be enrolled in this study.
Recruiting
1 award
Phase 1
4 criteria
SPX-303
for Solid Tumors
Part 1 of this study is an open-label, dose-escalation, and safety expansion study of an anti-LILRB2 / anti-PD-L1 bispecific antibody SPX- 303 in patients with solid tumors. Part 2 of this study is an indication-specific dose expansion study of SPX-303.
Recruiting
1 award
Phase 1
More about Justin Moser, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Justin Moser, MD has experience with
- Nivolumab
- Ipilimumab
- Novocure Optune
- Autologous T Cell Therapy
- TSC-204-A0201
- TSC-200-A0201
Breakdown of trials Justin Moser, MD has run
Solid Tumors
Melanoma
Lung Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Justin Moser, MD specialize in?
Justin Moser, MD focuses on Solid Tumors and Melanoma. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Justin Moser, MD currently recruiting for clinical trials?
Yes, Justin Moser, MD is currently recruiting for 8 clinical trials in Scottsdale Arizona. If you're interested in participating, you should apply.
Are there any treatments that Justin Moser, MD has studied deeply?
Yes, Justin Moser, MD has studied treatments such as Nivolumab, Ipilimumab, Novocure Optune.
What is the best way to schedule an appointment with Justin Moser, MD?
Apply for one of the trials that Justin Moser, MD is conducting.
What is the office address of Justin Moser, MD?
The office of Justin Moser, MD is located at: HonorHealth Research Institute, Scottsdale, Arizona 85258 United States. This is the address for their practice at the HonorHealth Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.